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and right atrium iRA) can be used terminate atrial fibrillation (AF) with low 
energies. Longer El apses or lengths could potentially lower thresholds es 
they might batter encompass the atria resulting in ~t mere uniform shock tiold 
strength, Therefore, the purpose of this study was to evaluate the effect cf 
longer El lengths on TAD thresholds, In 12 patients, 11 with spontaneous and 
1 with Induced AF, elective TAD wee pedormed, Two decepolar catheters 
were Inseded, one Into the distal CS end one in the RA, To provide longer El 
lengthS, a third catheter wan inserted and positioned, alternating In the RA 
or C$, In such a manner that the El on the two catheters were aligned tn a 
non.0verlapplng fashion, Thresholds were determined in a randomized order 
in each patlont for three combinations of electrodes; t0 El in the RA to O El tn 
the CS, 1& EI, RA to 8 Et-CS, and 8 EI,RA to 15 EI,GS, The O El had a linear 
span of O cm and the tS El was 11 cm, Thresholds were determined twice 
for e0(~h at~troda combination using a 0,5 J start, 0,S J st0p.up protocol, 
R~u~: All 1~ peflenta could Do successfully converted to etnue rhythm 
without complications, however one patient ceuld be converted with only 2 
of 3 El combinations, RopeMed below are the number of patients converted 
(n), threshold voltage, energy end Impedance for the 3 El epees (moon ~ 1 
e,d,I 
a ~m~a ~m ~4 ~0,I :t llS ~,,'I ~ ,1,3 7~ I ~O 
11 (~m~l ,~m 23 ~M~ f t00 5,~ t 3(] e~ t te 
(t Cm-'t t cm ~4 ~}Ft~ t 75 50 1 ~,tl 55 t: 11 
There w~re no signlficanl differences in threshold Vollago or energy 
associated with the different Et spans (p ~ 0,05) however the 11 cm span in 
the C~ significantly lowered shock Impedance es compared to the 6~ cm 
(p < 0,0S), 
Cond~k)n: The use of longer electrodes for TAD using the RA.CS shock 
vector dces not lower the 0nergy requirements for restoration of sinus rhythm, 
I101 9.1741 Safety of  Direct Current Conversion of  Atrial 
Arrhythmlao 
M,M, Gellagher, C,M, Hart, M,S, Shannon, O,A, Obal, NM, Al,Saady, 
A,J, Carom, Sf Georg~  Hoap#~tl M~c~I School, London, Unfte~t Kingo~om 
~ckg~ound: Direct currant eardlovor~lon (DCC) of ~trial fibrillation is ease. 
ctated with a risk of thrombcemboltsm. This is reduced but not eliminated 
by anttcoagutetlon, Nc series to date has Included enough patients renewing 
antice~gulants o estimate the risk of complications in this group. 
Methods: We ravlewed the case notes of 645 patients who undenNent 
attempted DCC on a total el 8B8 occasions between 1990 and 1997. 
Resells: 610 attempts et DCC were elective, with DCC _-3 weeks after 
dtagn0sis, DCC was preceded by warfann therapy for at least 3 weeks in 
483/490 cases of AF and in 801116 of flutter or areal techycandia, No embolic 
compltoatlon OcCurred in 2B8 attempls pedom~ed with an |NR ol -2.2. In 2~2 
cases the INR was ~2,2 and in 110 it was not measured on the day of DCC. 
6 worn complicated by Cerebral Infamtlon, I by symptoms suggestive of a 
putm~na~ embolus rind 1 by sudden dearth, e,t~ w~thin 4 days. In 123 cases 
of AI: of recent onset DCC was performed without anttceagutatlon or with 
hepadn ~lone, 2 of these were followed by cerebral infarction w~th|n 3 days, 
In 66 cases, atrial t~uffer wan eardtoverted within 3 weeks oi the estimated 
time of onset. None was Complicated by thrambosmbolism. 
Conclusion: INR must be ~-2.2 at the time of DCC if AF is chronic or of 
uncedaln duration, The risk of embolism after DCC of atrial flutter may be 
lower but still significant, 
L1 0 t9 - i751  Efficacy of  AF Detection and Safety of  R-Wave 
~ Synchronized Shocks for the Matrix Automatic 
Implantable Atrial Defibril lator 
H,-F Tee, C,-P, Lau, For the Mefr~x investigators: University of Hen 9 Kong, 
Queen Maw Hospital. Hang Kong. China 
For an automatic implantable atrial defibrillator (lAD) to function in the clinical 
setting, its ability to detect atrial fibrillation (AF) accurately is critical to avoid 
the ~elivery of spunous shocks to the conscious patient. More importantly, 
for the safety of an lAD, it must be able to appropriately synchronize shock 
delivery. The purpose of this study was to evaluate the ability of the Metnx 
lAD to detect AF and appropriately deliver R-wave synchronized shocks. 
The Metrix lAD was implanted in 51 patients with a mean age of 5E, ± t0 
years and LA size of 4.4 ~ 0.8 ca. At time of implant and at each follow-up 
Interval, AF dotection was performed during both sinus rhythm (NSR) and 
AF. The lAD algorithm results wee compared to the intrinsic rhythm to 
arrive at sensitivity to AF and specificity for NSR values. During the same 
testing penods, the device was programmed to electronically mark R-waves 
that would be appropnate for safe shock delivery. In addition, shocks were 
delivered for threshold testing and AF termination. During each follow.up, the 
stored electregrems wore also reviowod for device algorithm performance 
during Monitor mode exocutlon with patients in their ambient environment. 
Results: The device performed a total o! 1173 detections during AF and 
1057 detections during NSR, The detection algorithm had a specificity of 
100% for NSR and a sensitivity of 92.3% for AF, The peslflve end negative 
predictive values of the AF detection algorithm dudng obsee/ed execution 
were 100% and 92,6% respectively. 2237 etored electmgrems were reviewed 
o! which 2229 were confirmed to be AF and 6 tales posttlve detections 
were noted in 3 patients during time of efou8 tachyr.,amfla, Seven of thooa 
cocurmd In 2 patients and were dudng the first three months poM Implant, 
Those patient then had the device programmed to avoid de .on  at =me 
taohycardla while maintaining the ability to det~t AR One Pt, had a ein01o 
false positive deteotlon 4 months alter implant a~d ha= had no addtt '~l  
false positive detention (n the pant 12 months, A total of 230435 R,wevee 
were analyzed by the dovloo, All lAD quallfl~ R,wavea wQm ep~a~ 
for the preso,lce of the R.weve, Addltfonefly, 3719 cheeks were delivered 
tram the lAD with no evidence of venlr~ulor proardlythmia, The ventncular 
proeffhy~hmtc f, ek ta e=ime1~ tO be 0.084% per ~t~k,  
Conclusion: The Matrix lAD can dete~t AF with 100% spe~ti~ty, com~ctly 
ide¢ltlty ¢~ppropriata R.w~vcs far shark ~yeehmn;¢,~=~'4 a~d has beam us~:t 
to deliver more than 3700 sharks without vent~ular pmanhythmie, 
~ , i76]  In toml l  Card lowro lon  o f  Atrial  Fibril lation Using 
' Standard Ventrloular Implontoble 
Cardlovortor-!:Ntf!brl!lMom 
M,K, Cllung, M,J, Nieb~uer, B,L, Witkoff, F,J, Jaeger, G,A, Kldwell, 
VA, Morent, P,J, Tchou, The Cleveland Ctin~ Founda~on, Clerked, OH, 
USA 
Internal atrial defibrillation may be most ealely and readily applied to pat~mts 
with ventrtcular implanteble cardioverter.defibhllamm (!CDs). We sought to 
assess the efficacy of standard ventncular ICD configuratmne in the internal 
convemlon of atdal fibrillation (AF). 
Methods: Ounng ICD implantation, testing, or muhne can~ovemN~n, 30 
pie receiving ICD shocks during AF were studied, Severn of these ung~rwent 
internal CV attempts using their ICDs in a step.up protocol o1 R.wave syr~ 
chmni]md shocks to determine areal defibrillation threshold (AOFT). Fifteen 
pie were on amiodamne nd 2 were on sotalot. Duration at AF was -~4 days 
in 14 pts and _>2 rags in 15 pts. Mean LVEF was 29.8 ± 11.1% and left atrial 
size 53 ± 11 mm 76 shocks delivered dunng AF were evaluable tar efficacy 
in AF tenmtnation. 
Results: Successful CV el AF was achieved in 20,'30 pts (67%). Conver- 
sion to SR was achieved in 20/28 pie with nonthorecotomy lead systems, 
with epicardtal systems, 16/21 pts with active can. and 10/14 pie with sups- 
nor vena cave electrodes. Mean suocesstut delibnttabcn energy was 17.8 t; 
9.7,.I (range 5-34.7J) and ADFT was 10.2 ± 4.9.1 in Iho 5.q' pts successfully 
cardioverted dunng the ADFT protocol. Short AF duration was predebve of 
success (success in 15.'!5 pts with AF -2 rags, 5115 pts ~,~th AF ~2 rags, 
p = 0.002), as was smaller left sinai s~ze (50 ± 10 mm successful. 59 ± 10 
mm failed, p = 0.041). Electrode conliguretion did not predict success. 
Conclusions: Internal ICD shocks for AF convemton are a feasible attar. 
native to external cerdtoversion in pts w~th standard ICDs and particularly 
effective in pts with recent onset AF and smaller left aria. 
[ 1019-1 771 Inf luence of  Active Pectoral  ran  on 1Yansvenous 
Atrial Cardioversion Thresho ld  in Patients With 
Implantable Cardlovertsr ,  Def lbf l l lafor 
A. Heiset, J, Jung, R. Fries. H. Schieffer. Internal Medicine lU, Unzversity of 
San#and. Homburg, Germany 
Background: Recent studies have shown that low energy transvenous atrial 
cardiovemton is feasible with lead Configurations primarily designed for im- 
planteble ventncut.~r detibnSators (ICD). The purpose el this study was to 
investigate the influence o1 an active pectoral ICD can on the atrial cardiover- 
sign threshold. 
Methods: 27 consecutive patients (pie) (age: 56 ± 13 years, male: 22, 
CAD: 60%. LVEF: 0.42 ± 0.19) received a transvenous ingle lead alone 
system [Endotak DSP 0125, CPt, USA) in combination with a left subpectorat 
ICD (Ventak Mini, CPI) because of malignant ventncular tachyarrhythmias. 
Pts were randomized into 2 groups: 14 R.cetving a Hot Can 1T43 and 13 
pts a Cold Can 1741. Step-down testing of ventricular defibrillation threshold 
(VDFT) was performed intraoperafively and step-down testing of ADFT for 
Hot Can Cold Can p-value 
VOFT [J] 7.0 :t:: 24 8.3 ± 2.7 0,1 
ADFT [J| 3 2"~ 1.6 5.0 ~- 28 ~O,05 
impedance [Q'I 41 ± 5 55 ,~- 9 ~0,001 
induced atnal Cbrtllawn (AF) a( ~mdmcharge. Both groups were comparabte 
concemmg age. pend6f. heef! dlaease. LVEF. dmwwon ol tha len amum 
andprevmuaeplsodesolAF. 
Rrlsum:aeetable 
CMchMn. We conclude Ihat tha m@ementatmn al an 6cw WI sub 
peaorslcanIn~deRbn~~vsclwda~lrfICD~10~ 
nm 6hOch Impefhlnce and lim arsrgv f6aulmmQntl (Qf 6mal c6rdlovenm. 
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1020-113 surgkw cklsureof ~te!nl~!nl~Bi.st?Kt 
B. Cutec R. Mamr-a. D.H. Johnmn. C. Volt. Lhrrversily ol m 
sas&aRxn. Canads 
Backgaaduptoso%olpaIlents ~6OyrsoklmmstmkehavepaMll 
fotarnen OMIT (PFO). fhe retabve and altnbuMM nsk ol PFO tar recurrent 
ami@atelet. wadann. m dmrapy and s&rcal do& ol PFO: 
hMnnts: Follow-up was obtained on a rehlspeclnre cohortstudyd90 
pahents ~6OyrswhohadaTEEpedormedfoMwqacembral&mnnc 
event. 52 pahents had a PFO and 36 pabents had IY) PFO. flrg~bla patrents 
did not have any other car&c. hematokqc or vascular cause ot stmke. All 
recunent cerebral ischemk events were confmnod by a neurologst. 
Results: Tha rectmanca mte (TlA and CVA) was GFWpt-yf m the PFO 
group and SWpt-yr III Ihe control group (crude mcunence rate rat10 = 2.39. 
9%&l 1.01.6.32. p = 0.03) during an average follow-up of 2 years. Indepen- 
dent pradtctors (p c 0.01) of neumlqc recurrence m a @II* regmssmn 
model were: PFO (OR = 5.64). anhplatelet or no therapy compared lo war- 
farm (OR = 6.3). mlgrame htstory (OR = 6.6). hypertenson (OR = 4.4) and 
older age (OR = 1.1). 14 of 52 PFO p& had surgtcal dosure of PFO and no 
recurrent events occurred during a mean follow-up ot 23 months. 
Conclusions: Patients wilh PFO have a signifkantly higher rate of re- 
current neumlogic events than those without PFO. Surgical PFO closure 
prevented any recunences. Wartann was better than antiplatelet or no Iher- 
apy m preventing recurrences. 
(102@115~ ltmacoumeofLoRAtrbtThlwws andaovere 
:cebmsb tn the Ftmt Nins Months 
, 
R.L McMmam, S. Sew. S wrner, K Wu. L Wlnnar, J.A.C. Lna 
mmw 8a4emre~UsA 
-T-v 
(TEnheGZ!ZZZ lenatnalmrombus(-m)arKlsavrnsaomc~ 
6fb3fStfOkt?.Ulk?.tkY!M6W.l6lvwrwnabout~WlaCOllf6tOl~poMnbal 
SoufwSamdfk6f6dcef6bf6iemboll 
hbUfdxOtUmfifst44p66ef@manaqamgpospechva6tudy.we 
pe&rmedTEEwcmtnsavendayxarxtagammnemonthsafterahmtshoke 
m 31 (70%) paeents (mean age 56.9% m atnal iibnllahon). Followup TEE 
wss~perMneddu!atoratusal(Il)ordaam(2) 
Resutts:Ttlwas~ m 9i31(29%) mntatiy: 619 recewed armcoagt- 
Mon. Dn )ollowup TEE. TH was tound m 4 01 thou3 palmnts (4?*) and m 
4(1BO.)ofmePwho~rmmctlanyhaveTH.A~fano(Mepaaantsw1M 
newly idant~I~& TH had bee0 takmg aspinn. SAA. defined as greater than 
4mm.waskrundnl5(16%)paDenrsmrMuy.onloAovypTEE.SAAwas 
~m4(80$~)a(masa5pa~sndmone(4X)addbmcllpstlsnt 
carchanns:Leftahalfhmmbrcanbaperaqscl(. trwsrcory,~~rrem 
mtherirslrwnemonthraf?erstrohe.lnamWast.sevara~amarmrclsros~ 
vanashtiiemlhrsbmepenod. 
InW -FO&W-UO w SM 
Yes--m 4 4 
VeS-Ho 5 1 
No-m 4 1 
NO-NO 16 25 
a 1020 116 Cardiac Sources of Embolism: Value of lh- end Thee-dimensbnel Echucafdbgraphy In 
Therapeutk Declston-msktng 
S. Muller. T Bartel. H.C. Dmner. A Dekkef. R Erbel lJn~~%‘mfy Es%?n. 
afmanv 
Badqmur& The aim of me study was fo assess fhe use of hvo- and Ihme- 
dm?ensnr =I (2D ar. ?r)) transasophageal KhoGardtography (TEE) tOfttM!f- 
apeurn fffa3~pn6nt n potenhal cardiac 3nd aorfrc soumesofemborwrnam 
hfenrc&: Patients ti hansr?ory ~schemtc attack (TIA) and r.chennc 
stroke (IS) were screened for the presence of potential cardiac and a0mc 
SOUSES of embohsm uslnq ~tandardued 2D EE. In 22 mndomlzed patias 
3D TEE was ernptoyezl addihonally. 
&sum: Eighty-sm3-t po&nlmi .9wct5 01 embolism could be deteded 
in 55 (MY’.) md~&aii: patent foramen tile (PFO) (n = 15). amal sePml 
aneurysms (n = 11). atnal septal de%% (n = 3). left amal Clots (n = 6). lefl 
